These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 14500385)

  • 1. Role of MutSalpha in the recognition of iododeoxyuridine in DNA.
    Berry SE; Loh T; Yan T; Kinsella TJ
    Cancer Res; 2003 Sep; 63(17):5490-5. PubMed ID: 14500385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective radiosensitization of drug-resistant MutS homologue-2 (MSH2) mismatch repair-deficient cells by halogenated thymidine (dThd) analogues: Msh2 mediates dThd analogue DNA levels and the differential cytotoxicity and cell cycle effects of the dThd analogues and 6-thioguanine.
    Berry SE; Davis TW; Schupp JE; Hwang HS; de Wind N; Kinsella TJ
    Cancer Res; 2000 Oct; 60(20):5773-80. PubMed ID: 11059773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mismatch repair protein, hMLH1, mediates 5-substituted halogenated thymidine analogue cytotoxicity, DNA incorporation, and radiosensitization in human colon cancer cells.
    Berry SE; Garces C; Hwang HS; Kunugi K; Meyers M; Davis TW; Boothman DA; Kinsella TJ
    Cancer Res; 1999 Apr; 59(8):1840-5. PubMed ID: 10213489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of base excision repair potentiates iododeoxyuridine-induced cytotoxicity and radiosensitization.
    Taverna P; Hwang HS; Schupp JE; Radivoyevitch T; Session NN; Reddy G; Zarling DA; Kinsella TJ
    Cancer Res; 2003 Feb; 63(4):838-46. PubMed ID: 12591735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions of the DNA mismatch repair proteins MLH1 and MSH2 with c-MYC and MAX.
    Mac Partlin M; Homer E; Robinson H; McCormick CJ; Crouch DH; Durant ST; Matheson EC; Hall AG; Gillespie DA; Brown R
    Oncogene; 2003 Feb; 22(6):819-25. PubMed ID: 12584560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear translocation of mismatch repair proteins MSH2 and MSH6 as a response of cells to alkylating agents.
    Christmann M; Kaina B
    J Biol Chem; 2000 Nov; 275(46):36256-62. PubMed ID: 10954713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of MLH1 and MSH2 DNA mismatch repair proteins in cell lines of the NCI anticancer drug screen.
    Taverna P; Liu L; Hanson AJ; Monks A; Gerson SL
    Cancer Chemother Pharmacol; 2000; 46(6):507-16. PubMed ID: 11138465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient repair of A/C mismatches in mouse cells deficient in long-patch mismatch repair.
    Oda S; Humbert O; Fiumicino S; Bignami M; Karran P
    EMBO J; 2000 Apr; 19(7):1711-8. PubMed ID: 10747038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in PMS2, MSH2 and MLH1 expression in human prostate cancer.
    Chen Y; Wang J; Fraig MM; Henderson K; Bissada NK; Watson DK; Schweinfest CW
    Int J Oncol; 2003 May; 22(5):1033-43. PubMed ID: 12684669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylation of mismatch repair proteins MSH2 and MSH6 affecting MutSalpha mismatch-binding activity.
    Christmann M; Tomicic MT; Kaina B
    Nucleic Acids Res; 2002 May; 30(9):1959-66. PubMed ID: 11972333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular characterization of the spectrum of genomic deletions in the mismatch repair genes MSH2, MLH1, MSH6, and PMS2 responsible for hereditary nonpolyposis colorectal cancer (HNPCC).
    van der Klift H; Wijnen J; Wagner A; Verkuilen P; Tops C; Otway R; Kohonen-Corish M; Vasen H; Oliani C; Barana D; Moller P; Delozier-Blanchet C; Hutter P; Foulkes W; Lynch H; Burn J; Möslein G; Fodde R
    Genes Chromosomes Cancer; 2005 Oct; 44(2):123-38. PubMed ID: 15942939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting DNA mismatch repair for radiosensitization.
    Berry SE; Kinsella TJ
    Semin Radiat Oncol; 2001 Oct; 11(4):300-15. PubMed ID: 11677655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mlh1 can function in antibody class switch recombination independently of Msh2.
    Schrader CE; Vardo J; Stavnezer J
    J Exp Med; 2003 May; 197(10):1377-83. PubMed ID: 12743174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemistry and microsatellite instability testing for selecting MLH1, MSH2 and MSH6 mutation carriers in hereditary non-polyposis colorectal cancer.
    Caldés T; Godino J; Sanchez A; Corbacho C; De la Hoya M; Lopez Asenjo J; Saez C; Sanz J; Benito M; Ramon Y Cajal S; Diaz-Rubio E
    Oncol Rep; 2004 Sep; 12(3):621-9. PubMed ID: 15289847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of MLH1, MSH2 and MSH6 in the development of multiple colorectal cancers.
    Lawes DA; Pearson T; Sengupta S; Boulos PB
    Br J Cancer; 2005 Aug; 93(4):472-7. PubMed ID: 16106253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo modulations of benzo[c]phenanthrene-DNA adducts by DNA mismatch repair system.
    Wu J; Zhu BB; Yu J; Zhu H; Qiu L; Kindy MS; Gu L; Seidel A; Li GM
    Nucleic Acids Res; 2003 Nov; 31(22):6428-34. PubMed ID: 14602900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differing patterns of genetic instability in mice deficient in the mismatch repair genes Pms2, Mlh1, Msh2, Msh3 and Msh6.
    Hegan DC; Narayanan L; Jirik FR; Edelmann W; Liskay RM; Glazer PM
    Carcinogenesis; 2006 Dec; 27(12):2402-8. PubMed ID: 16728433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myc down-regulation sensitizes melanoma cells to radiotherapy by inhibiting MLH1 and MSH2 mismatch repair proteins.
    Bucci B; D'Agnano I; Amendola D; Citti A; Raza GH; Miceli R; De Paula U; Marchese R; Albini S; Felsani A; Brunetti E; Vecchione A
    Clin Cancer Res; 2005 Apr; 11(7):2756-67. PubMed ID: 15814658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The first molecular analysis of a Hungarian HNPCC family: a novel MSH2 germline mutation].
    Czakó L; Tiszlavicz L; Takács R; Baradnay G; Lonovics J; Cserni G; Závodná K; Bartosova Z
    Orv Hetil; 2005 May; 146(20):1009-16. PubMed ID: 15945244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered expression and new mutations in DNA mismatch repair genes MLH1 and MSH2 in melanoma brain metastases.
    Korabiowska M; König F; Verheggen R; Schlott T; Cordon-Cardo C; Romeike B; Brinck U
    Anticancer Res; 2004; 24(2B):981-6. PubMed ID: 15161053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.